Evidence map›Paper›PMID 36817053›Full record

ArticleOncology letters2023

Treatment of spinal rhabdomyosarcoma in adults: A case report and literature review of current evidence.

Suiyong Du, Panpan Hu, Hongqing Zhuang, Shaomin Yang, Feng Wei

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Suiyong DuDepartment of Orthopaedics, Peking University Third Hospital, Beijing 100191, P.R. China.
Panpan HuDepartment of Orthopaedics, Peking University Third Hospital, Beijing 100191, P.R. China.
Hongqing ZhuangDepartment of Radiation Oncology, Peking University Third Hospital, Beijing 100191, P.R. China.
Shaomin YangDepartment of Pathology, Peking University Third Hospital, Beijing 100191, P.R. China.
Feng WeiDepartment of Orthopaedics, Peking University Third Hospital, Beijing 100191, P.R. China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal rhabdomyosarcoma (RMS) is a rare yet highly malignant tumor in adults. Literature on this entity is lacking and no mature treatment guideline is currently available. The treatment arsenals include surgery, radiotherapy and chemotherapy, being used singly or jointly. However, the prognosis is dismal, with a mean overall survival period of 10 months. Thus, any case of this disease with encouraging outcomes shall be shared. A case of a middle-aged female patient with spinal RMS was presented in the current report. The patient suffered from back pain but was neurologically intact. The patient underwent a total

Indexed as

3D printingcase reportrhabdomyosarcomaspinestereotactic body radiotherapytotal en-bloc spondylectomy

Identifiers

PMID36817053
PMCPMC9931996
OpenAlexW4318480176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.